Cargando…
Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines in infants and young children
Human parainfluenza virus type 3 (HPIV3) is an important cause of lower respiratory tract illness in children, yet a licensed vaccine or antiviral drug is not available. We evaluated the safety, tolerability, infectivity, and immunogenicity of two intranasal, live-attenuated HPIV3 vaccines, designat...
Autores principales: | Karron, Ruth A., Thumar, Bhagvanji, Schappell, Elizabeth, Surman, Sonja, Murphy, Brian R., Collins, Peter L., Schmidt, Alexander C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509782/ https://www.ncbi.nlm.nih.gov/pubmed/22178099 http://dx.doi.org/10.1016/j.vaccine.2011.12.022 |
Ejemplares similares
-
Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children()
por: Englund, Janet A., et al.
Publicado: (2013) -
Live-Attenuated Respiratory Syncytial Virus Vaccine With Deletion of RNA Synthesis Regulatory Protein M2-2 and Cold Passage Mutations Is Overattenuated
por: Cunningham, Coleen K, et al.
Publicado: (2019) -
Attenuation and efficacy of human parainfluenza virus type 1 (HPIV1) vaccine candidates containing stabilized mutations in the P/C and L genes
por: Bartlett, Emmalene J, et al.
Publicado: (2007) -
Evaluation of fast-track diagnostics and TaqMan array card real-time PCR assays for the detection of respiratory pathogens
por: Driscoll, Amanda J., et al.
Publicado: (2014) -
The C Proteins of Human Parainfluenza Virus Type 1 Block IFN Signaling by Binding and Retaining Stat1 in Perinuclear Aggregates at the Late Endosome
por: Schomacker, Henrick, et al.
Publicado: (2012)